Atlas Trials

Efficacy and Safety of Vildagliptin in Combination With Insulin in Patients With Type 2 Diabetes

Clinical trial NCT00099931 · COMPLETED

Trial details

NCT number
NCT00099931
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2
Start date
2004-05-01
Primary completion
2005-06-01
Enrollment
254

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.